Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12935-021-02433-6.

Title:
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification | Cancer Cell International
Description:
Background N6-methyladenosine (m6A) has emerged as a significant regulator of the progress of various cancers. However, its role in lung adenocarcinoma (LUAD) remains unclear. Here, we explored the biological function and underlying mechanism of methyltransferase-like 3 (METTL3), the main catalyst of m6A, in LUAD progression. Methods The expression of m6A, METTL3, YTHDF1 and SLC7A11 were detected by immunochemistry or/and online datasets in LUAD patients. The effects of METTL3 on LUAD cell proliferation, apoptosis and ferroptosis were assessed through in vitro loss-and gain-of-function experiments. The in vivo effect on tumorigenesis of METTL3 was evaluated using the LUAD cell xenograft mouse model. MeRIP-seq, RNA immunoprecipitation and RNA stability assay were conducted to explore the molecular mechanism of METTL3 in LUAD. Results The results showed that the m6A level, as well as the methylase METTL3 were both significantly elevated in LUAD patients and lung cancer cells. Functionally, we found that METTL3 could promote proliferation and inhibit ferroptosis in different LUAD cell models, while METTL3 knockdown suppressed LUAD growth in cell-derived xenografts. Mechanistically, solute carrier 7A11 (SLC7A11), the subunit of system Xc−, was identified as the direct target of METTL3 by mRNA-seq and MeRIP-seq. METTL3-mediated m6A modification could stabilize SLC7A11 mRNA and promote its translation, thus promoting LUAD cell proliferation and inhibiting cell ferroptosis, a novel form of programmed cell death. Additionally, we demonstrated that YTHDF1, a m6A reader, was recruited by METTL3 to enhance SLC7A11 m6A modification. Moreover, the expression of YTHDF1 and SLC7A11 were positively correlated with METTL3 and m6A in LUAD tissues. Conclusions These findings reinforced the oncogenic role of METTL3 in LUAD progression and revealed its underlying correlation with cancer cell ferroptosis; these findings also indicate that METTL3 is a promising novel target in LUAD diagnosis and therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

mettl, cells, luad, slca, cell, pubmed, cancer, ferroptosis, fig, google, scholar, knockdown, rna, expression, ythdf, mrna, cas, modification, lung, overexpression, central, analysis, zhang, levels, showed, protein, tumor, patients, ihc, progression, level, mettlmediated, control, data, growth, translation, chen, wang, stability, role, proliferation, found, liu, assays, western, blot, promotes, adenocarcinoma, apoptosis, effect,

Topics {✒️}

tgf-β-induced epithelial-mesenchymal transition annexin v-fitc/pi staining kras-mutant lung adenocarcinoma renal ischemia/reperfusion injury stimulate eno1-dependent glycolysis lipid-reactive oxygen species epithelial mesenchymal transition cystine deprivation-induced ferroptosis methylated rna immune-precipitation ischemia/reperfusion-related damage [33 small-cell lung cancer kaplan–meier os analysis ferroptosis-mediated tissue injury cancer n6-methyladenosine modification strand-specific library preparation lc-bio bio-tech intestinal ischemia/reperfusion ca2+/cam-dependent pathway cystine/glutamate antiporter xct article download pdf mettl3-mediated m6a modification real-time quantitative pcr hrp-conjugated secondary antibodies specific pathogen-free conditions focad-fak signaling pathway oligo-attached magnetic beads m6a-igf2bp2/3-dependent manner [23] calcium/calmodulin-dependent ferroptosis cell-derived xenografts exhibited cystine transporter slc7a11/xct cancer-related mortalities worldwide significant inhibitory effect mettl3-deficient group grew pancreatic ductal adenocarcinoma full access ap-mn-ms-rna-250 nuclear factor-erythroid 2 enhancing c-myc stability acute myeloid leukemia slc7a11 mrna half-lives oncogenic kras-mutant cancers iron-dependent ros production pex-3-mettl3 expression plasmid rip-qpcr analysis showed rna n6-methyladenosine potential anti-tumor effect privacy choices/manage cookies rna immune-precipitation lung adenocarcinoma mettl3-mediated methylation

Schema {🗺️}

WebPage:
      mainEntity:
         headline:METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification
         description:N6-methyladenosine (m6A) has emerged as a significant regulator of the progress of various cancers. However, its role in lung adenocarcinoma (LUAD) remains unclear. Here, we explored the biological function and underlying mechanism of methyltransferase-like 3 (METTL3), the main catalyst of m6A, in LUAD progression. The expression of m6A, METTL3, YTHDF1 and SLC7A11 were detected by immunochemistry or/and online datasets in LUAD patients. The effects of METTL3 on LUAD cell proliferation, apoptosis and ferroptosis were assessed through in vitro loss-and gain-of-function experiments. The in vivo effect on tumorigenesis of METTL3 was evaluated using the LUAD cell xenograft mouse model. MeRIP-seq, RNA immunoprecipitation and RNA stability assay were conducted to explore the molecular mechanism of METTL3 in LUAD. The results showed that the m6A level, as well as the methylase METTL3 were both significantly elevated in LUAD patients and lung cancer cells. Functionally, we found that METTL3 could promote proliferation and inhibit ferroptosis in different LUAD cell models, while METTL3 knockdown suppressed LUAD growth in cell-derived xenografts. Mechanistically, solute carrier 7A11 (SLC7A11), the subunit of system Xc−, was identified as the direct target of METTL3 by mRNA-seq and MeRIP-seq. METTL3-mediated m6A modification could stabilize SLC7A11 mRNA and promote its translation, thus promoting LUAD cell proliferation and inhibiting cell ferroptosis, a novel form of programmed cell death. Additionally, we demonstrated that YTHDF1, a m6A reader, was recruited by METTL3 to enhance SLC7A11 m6A modification. Moreover, the expression of YTHDF1 and SLC7A11 were positively correlated with METTL3 and m6A in LUAD tissues. These findings reinforced the oncogenic role of METTL3 in LUAD progression and revealed its underlying correlation with cancer cell ferroptosis; these findings also indicate that METTL3 is a promising novel target in LUAD diagnosis and therapy.
         datePublished:2022-01-07T00:00:00Z
         dateModified:2022-01-07T00:00:00Z
         pageStart:1
         pageEnd:16
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12935-021-02433-6
         keywords:
            Lung adenocarcinoma
            METTL3
            N6-methyladenosine (m6a) modification
            Ferroptosis
            SLC7A11
            Cancer Research
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig6_HTML.png
         isPartOf:
            name:Cancer Cell International
            issn:
               1475-2867
            volumeNumber:22
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yiming Xu
               affiliation:
                     name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                     address:
                        name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Zhejiang University
                     address:
                        name:Cancer Center, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dandan Lv
               affiliation:
                     name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                     address:
                        name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Zhejiang University
                     address:
                        name:Cancer Center, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chao Yan
               affiliation:
                     name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                     address:
                        name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Zhejiang University
                     address:
                        name:Cancer Center, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hua Su
               affiliation:
                     name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                     address:
                        name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Zhejiang University
                     address:
                        name:Cancer Center, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xue Zhang
               affiliation:
                     name:Zhejiang University School of Medicine
                     address:
                        name:Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yangfeng Shi
               affiliation:
                     name:Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine
                     address:
                        name:Department of Respiratory and Critical Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Kejing Ying
               url:http://orcid.org/0000-0001-9642-3929
               affiliation:
                     name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                     address:
                        name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Zhejiang University
                     address:
                        name:Cancer Center, Zhejiang University, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification
      description:N6-methyladenosine (m6A) has emerged as a significant regulator of the progress of various cancers. However, its role in lung adenocarcinoma (LUAD) remains unclear. Here, we explored the biological function and underlying mechanism of methyltransferase-like 3 (METTL3), the main catalyst of m6A, in LUAD progression. The expression of m6A, METTL3, YTHDF1 and SLC7A11 were detected by immunochemistry or/and online datasets in LUAD patients. The effects of METTL3 on LUAD cell proliferation, apoptosis and ferroptosis were assessed through in vitro loss-and gain-of-function experiments. The in vivo effect on tumorigenesis of METTL3 was evaluated using the LUAD cell xenograft mouse model. MeRIP-seq, RNA immunoprecipitation and RNA stability assay were conducted to explore the molecular mechanism of METTL3 in LUAD. The results showed that the m6A level, as well as the methylase METTL3 were both significantly elevated in LUAD patients and lung cancer cells. Functionally, we found that METTL3 could promote proliferation and inhibit ferroptosis in different LUAD cell models, while METTL3 knockdown suppressed LUAD growth in cell-derived xenografts. Mechanistically, solute carrier 7A11 (SLC7A11), the subunit of system Xc−, was identified as the direct target of METTL3 by mRNA-seq and MeRIP-seq. METTL3-mediated m6A modification could stabilize SLC7A11 mRNA and promote its translation, thus promoting LUAD cell proliferation and inhibiting cell ferroptosis, a novel form of programmed cell death. Additionally, we demonstrated that YTHDF1, a m6A reader, was recruited by METTL3 to enhance SLC7A11 m6A modification. Moreover, the expression of YTHDF1 and SLC7A11 were positively correlated with METTL3 and m6A in LUAD tissues. These findings reinforced the oncogenic role of METTL3 in LUAD progression and revealed its underlying correlation with cancer cell ferroptosis; these findings also indicate that METTL3 is a promising novel target in LUAD diagnosis and therapy.
      datePublished:2022-01-07T00:00:00Z
      dateModified:2022-01-07T00:00:00Z
      pageStart:1
      pageEnd:16
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12935-021-02433-6
      keywords:
         Lung adenocarcinoma
         METTL3
         N6-methyladenosine (m6a) modification
         Ferroptosis
         SLC7A11
         Cancer Research
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02433-6/MediaObjects/12935_2021_2433_Fig6_HTML.png
      isPartOf:
         name:Cancer Cell International
         issn:
            1475-2867
         volumeNumber:22
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yiming Xu
            affiliation:
                  name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                  address:
                     name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Zhejiang University
                  address:
                     name:Cancer Center, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dandan Lv
            affiliation:
                  name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                  address:
                     name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Zhejiang University
                  address:
                     name:Cancer Center, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chao Yan
            affiliation:
                  name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                  address:
                     name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Zhejiang University
                  address:
                     name:Cancer Center, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hua Su
            affiliation:
                  name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                  address:
                     name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Zhejiang University
                  address:
                     name:Cancer Center, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xue Zhang
            affiliation:
                  name:Zhejiang University School of Medicine
                  address:
                     name:Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yangfeng Shi
            affiliation:
                  name:Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine
                  address:
                     name:Department of Respiratory and Critical Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Kejing Ying
            url:http://orcid.org/0000-0001-9642-3929
            affiliation:
                  name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
                  address:
                     name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Zhejiang University
                  address:
                     name:Cancer Center, Zhejiang University, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer Cell International
      issn:
         1475-2867
      volumeNumber:22
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      address:
         name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Cancer Center, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      address:
         name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Cancer Center, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      address:
         name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Cancer Center, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      address:
         name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Cancer Center, Zhejiang University, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University School of Medicine
      address:
         name:Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, China
         type:PostalAddress
      name:Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine
      address:
         name:Department of Respiratory and Critical Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
         type:PostalAddress
      name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      address:
         name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
         type:PostalAddress
      name:Zhejiang University
      address:
         name:Cancer Center, Zhejiang University, Hangzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yiming Xu
      affiliation:
            name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
            address:
               name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
               type:PostalAddress
            type:Organization
            name:Zhejiang University
            address:
               name:Cancer Center, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Dandan Lv
      affiliation:
            name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
            address:
               name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
               type:PostalAddress
            type:Organization
            name:Zhejiang University
            address:
               name:Cancer Center, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Chao Yan
      affiliation:
            name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
            address:
               name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
               type:PostalAddress
            type:Organization
            name:Zhejiang University
            address:
               name:Cancer Center, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Hua Su
      affiliation:
            name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
            address:
               name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
               type:PostalAddress
            type:Organization
            name:Zhejiang University
            address:
               name:Cancer Center, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Xue Zhang
      affiliation:
            name:Zhejiang University School of Medicine
            address:
               name:Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Yangfeng Shi
      affiliation:
            name:Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine
            address:
               name:Department of Respiratory and Critical Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Kejing Ying
      url:http://orcid.org/0000-0001-9642-3929
      affiliation:
            name:Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
            address:
               name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
               type:PostalAddress
            type:Organization
            name:Zhejiang University
            address:
               name:Cancer Center, Zhejiang University, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
      name:Cancer Center, Zhejiang University, Hangzhou, China
      name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
      name:Cancer Center, Zhejiang University, Hangzhou, China
      name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
      name:Cancer Center, Zhejiang University, Hangzhou, China
      name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
      name:Cancer Center, Zhejiang University, Hangzhou, China
      name:Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, China
      name:Department of Respiratory and Critical Medicine, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
      name:Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
      name:Cancer Center, Zhejiang University, Hangzhou, China

External Links {🔗}(172)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.63s.